Karyopharm Therapeutics (KPTI) PT Raised to $37 at RBC Capital
RBC Capital analyst Brian Abrahams raised the price ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
